Archived Seminar: Engineering the Bio/Nano Interface for Enhanced Nano-Immunotherapy
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Engineering the Bio/Nano Interface for Enhanced Nano-Immunotherapy
Date: Nov. 13, 2020
Time: 11:00 a.m. - 12:00 p.m.
About This Seminar
Self-assembled nanobiomaterials that are engineered to achieve specific biodistributions and mechanisms of degradation hold great promise for controlled stimulation of the immune system. Taking advantage of the morphological flexibility of self-assembled systems, we aim to mimic various structures and biochemical mechanisms of pathogens to enhance cell-selective intracellular delivery and treatment efficacy during immunotherapy. Dr. Scott and his team specifically approach this by synthesizing, assembling and optimizing in vitro and in vivo a range of nanostructures loaded with strategically selected combinations of immunostimulants to achieve controlled activation or suppression of the immune system. Dr. Scott will present some of our ongoing work in the area of novel nanobiomaterials development and interactions at the bio/nano interface, as well as recent applications of our materials for the controlled modulation of cells for a variety of therapeutic applications, including cell/organ transplantation, vaccination, and treatment of atherosclerosis, glaucoma and infectious diseases.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home Item
Inheriting Chromatin Domains in Mammals and the Mechanisms Involved , homeSept. 5, 2025, 11:00 a.m. | Thelma Escobar, Ph.D., Assistant Professor, Department of Biochemistry, Institute for Stem Cell & Regenerative Medicine, University of Washington | Co-Sponsored by the Fralin Biomedical Research Institute and Cancer Research Center — D.C.
-
Home Item
Flow Induced Endothelial Planar Polarity for Signaling Regulation , homeSept. 19, 2025, 11:00 a.m. | Julia Mack, Ph.D., Assistant Adjunct Professor, David Geffen School of Medicine, Division of Cardiology, University of California Los Angeles | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , homeOct. 3, 2025, 11:00 a.m. | Paule Valery Joseph, Ph.D., Lasker Clinical Research Scholar, NIH Distinguished Scholar; Acting Chief, Section of Sensory Science and Metabolism Unit, Co-Director of the National Smell and Taste Center, National Institute on Deafness and Other Communication Disorders; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home Item
Organization and Control of Hippocampal Networks , homeOct. 17, 2025, 11:00 a.m. | Ivan Soltesz, Ph.D., James R. Doty Professor of Neurosurgery and Neurosciences, Stanford University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
Thinking the Right Thoughts , homeOct. 31, 2025, 11 a.m. | Nathaniel Daw, Ph.D., Professor, Computational and Theoretical Neuroscience, Department of Psychology, Princeton University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
Evan Scott, Ph.D.
Kay Davis Professor of Biomedical Engineering and Microbiology-Immunology in the Robert R. McCormick School of Engineering and Applied Science at Northwestern Medicine Feinberg School of Medicine